JFAN-1001

N/A

Report date: 2022/10/25 13:05:03
NME

Base Information

Drug NameJFAN-1001
Drug Alias NameJFAN-1001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEGFR T790M inhibitors
TargetsEGFR T790M
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesZhejiang Jianfeng Pharmaceutical Macutical Holdings
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZhejiang Jianfeng Yien Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A